[1]
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition. Diabetes care. 2015 Sep:38(9):1687-93. doi: 10.2337/dc15-0843. Epub 2015 Jun 15
[PubMed PMID: 26078479]
[2]
Modi A,Agrawal A,Morgan F, Euglycemic Diabetic Ketoacidosis: A Review. Current diabetes reviews. 2017;
[PubMed PMID: 27097605]
[3]
Rawla P,Vellipuram AR,Bandaru SS,Pradeep Raj J, Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinology, diabetes
[PubMed PMID: 28924481]
[4]
Nasa P,Chaudhary S,Shrivastava PK,Singh A, Euglycemic diabetic ketoacidosis: A missed diagnosis. World journal of diabetes. 2021 May 15
[PubMed PMID: 33995841]
[5]
Wazir S,Shittu S,Dukhan K,Sharief M,Beer S,Malik W,Alansari L, Euglycemic diabetic ketoacidosis in pregnancy with COVID-19: A case report and literature review. Clinical case reports. 2022 Apr
[PubMed PMID: 35414931]
Level 3 (low-level) evidence
[6]
Guo RX,Yang LZ,Li LX,Zhao XP, Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. The journal of obstetrics and gynaecology research. 2008 Jun;
[PubMed PMID: 18588610]
Level 2 (mid-level) evidence
[7]
Madaan M,Aggarwal K,Sharma R,Trivedi SS, Diabetic ketoacidosis occurring with lower blood glucose levels in pregnancy: a report of two cases. The Journal of reproductive medicine. 2012 Sep-Oct;
[PubMed PMID: 23091997]
Level 3 (low-level) evidence
[8]
Dowsett J,Humphreys R,Krones R, Normal Blood Glucose and High Blood Ketones in a Critically Unwell Patient with T1DM Post-Bariatric Surgery: a Case of Euglycemic Diabetic Ketoacidosis. Obesity surgery. 2019 Jan;
[PubMed PMID: 30328578]
Level 3 (low-level) evidence
[9]
Yu X,Zhang S,Zhang L, Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis. International journal of endocrinology. 2018;
[PubMed PMID: 30369948]
Level 3 (low-level) evidence
[10]
Goldenberg RM,Berard LD,Cheng AYY,Gilbert JD,Verma S,Woo VC,Yale JF, SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis. Clinical therapeutics. 2016 Dec;
[PubMed PMID: 28003053]
[11]
Joseph F,Anderson L,Goenka N,Vora J, Starvation-induced true diabetic euglycemic ketoacidosis in severe depression. Journal of general internal medicine. 2009 Jan;
[PubMed PMID: 18975036]
[12]
Burge MR,Garcia N,Qualls CR,Schade DS, Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis. Metabolism: clinical and experimental. 2001 Feb;
[PubMed PMID: 11229425]
[13]
Secinaro E,Ciavarella S,Rizzo G,Porreca E,Vitacolonna E, SGLT2-inhibitors and euglycemic diabetic ketoacidosis in COVID-19 pandemic era: a case report. Acta diabetologica. 2022 Jun 19
[PubMed PMID: 35718795]
Level 3 (low-level) evidence
[14]
Legaspi R,Narciso P, Euglycemic Diabetic Ketoacidosis Due to Gastroparesis, A Local Experience. The Journal of the Arkansas Medical Society. 2015 Sep;
[PubMed PMID: 26390536]
[15]
Jenkins D,Close CF,Krentz AJ,Nattrass M,Wright AD, Euglycaemic diabetic ketoacidosis: does it exist? Acta diabetologica. 1993;
[PubMed PMID: 8180418]
[16]
Blau JE,Tella SH,Taylor SI,Rother KI, Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes/metabolism research and reviews. 2017 Nov;
[PubMed PMID: 28736981]
[17]
Erondu N,Desai M,Ways K,Meininger G, Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes care. 2015 Sep;
[PubMed PMID: 26203064]
[18]
Taylor SI,Blau JE,Rother KI, SGLT2 Inhibitors May Predispose to Ketoacidosis. The Journal of clinical endocrinology and metabolism. 2015 Aug;
[PubMed PMID: 26086329]
[19]
Somagutta MR,Agadi K,Hange N,Jain MS,Batti E,Emuze BO,Amos-Arowoshegbe EO,Popescu S,Hanan S,Kumar VR,Pormento K, Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers. Cureus. 2021 Mar 3;
[PubMed PMID: 33824816]
[20]
Rosenstock J,Ferrannini E, Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors. Diabetes care. 2015 Sep;
[PubMed PMID: 26294774]
[21]
Henry RR,Thakkar P,Tong C,Polidori D,Alba M, Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes. Diabetes care. 2015 Dec;
[PubMed PMID: 26486192]
[22]
Pfützner A,Klonoff D,Heinemann L,Ejskjaer N,Pickup J, Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology. Endocrine. 2017 Apr;
[PubMed PMID: 28303514]
[23]
Bonner C,Kerr-Conte J,Gmyr V,Queniat G,Moerman E,Thévenet J,Beaucamps C,Delalleau N,Popescu I,Malaisse WJ,Sener A,Deprez B,Abderrahmani A,Staels B,Pattou F, Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nature medicine. 2015 May;
[PubMed PMID: 25894829]
[24]
Ferrannini E,Muscelli E,Frascerra S,Baldi S,Mari A,Heise T,Broedl UC,Woerle HJ, Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. The Journal of clinical investigation. 2014 Feb;
[PubMed PMID: 24463454]
[25]
Crespo L,McConnell B,Wick JY, Euglycemic Diabetic Ketoacidosis: Hidden in Plain Sight. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 2016;
[PubMed PMID: 27535077]
[26]
Umpierrez GE, Diabetes: SGLT2 inhibitors and diabetic ketoacidosis - a growing concern. Nature reviews. Endocrinology. 2017 Aug;
[PubMed PMID: 28621337]
[27]
Bader N,Mirza L, Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin. Pakistan journal of medical sciences. 2016 May-Jun;
[PubMed PMID: 27375734]
[28]
Sinha N,Venkatram S,Diaz-Fuentes G, Starvation ketoacidosis: a cause of severe anion gap metabolic acidosis in pregnancy. Case reports in critical care. 2014;
[PubMed PMID: 24963418]
Level 3 (low-level) evidence
[29]
Lucero P,Chapela S, Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature. Case reports in critical care. 2018;
[PubMed PMID: 30364093]
Level 3 (low-level) evidence
[30]
Dass B,Beck A,Holmes C,Morton G, Euglycemic DKA (euDKA) as a presentation of COVID-19. Clinical case reports. 2021 Jan;
[PubMed PMID: 33362928]
Level 3 (low-level) evidence
[31]
Dhatariya K, Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis. The review of diabetic studies : RDS. 2016 Winter;
[PubMed PMID: 28278308]
[32]
Kang CY,Khamooshi P,Reyes Pinzon V, An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists. Cureus. 2022 Apr
[PubMed PMID: 35573514]
Level 3 (low-level) evidence
[33]
Fernandez Felix DA,Madrigal Loria G,Sharma S,Sharma S,Arias Morales CE, A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis. Cureus. 2022 Jun
[PubMed PMID: 35698468]
Level 3 (low-level) evidence
[34]
Munro JF,Campbell IW,McCuish AC,Duncan LJ, Euglycaemic diabetic ketoacidosis. British medical journal. 1973 Jun 9;
[PubMed PMID: 4197425]
[35]
Wan Azman SS,Sukor N,Abu Shamsi MY,Ismail I,Kamaruddin NA, Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis. Frontiers in endocrinology. 2022
[PubMed PMID: 35712244]
Level 3 (low-level) evidence
[36]
Nyenwe EA,Kitabchi AE, The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism: clinical and experimental. 2016 Apr;
[PubMed PMID: 26975543]
[37]
Zughaib MT,Patel K,Leka M,Affas S, Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip. Cureus. 2022 Jan;
[PubMed PMID: 35251838]
[38]
Dai Z,Nishihata Y,Kawamatsu N,Komatsu I,Mizuno A,Shimizu M,Toya N,Ishimatsu S,Komiyama N, Cardiac arrest from acute myocardial infarction complicated with sodium-glucose cotransporter 2 inhibitor-associated ketoacidosis. Journal of cardiology cases. 2017 Feb;
[PubMed PMID: 30546697]
Level 3 (low-level) evidence
[39]
Dalfrà MG,Burlina S,Sartore G,Lapolla A, Ketoacidosis in diabetic pregnancy. The journal of maternal-fetal
[PubMed PMID: 26461169]
[40]
Tarif N,Al Badr W, Euglycemic diabetic ketoacidosis in pregnancy. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2007 Nov;
[PubMed PMID: 17951948]
[41]
Packer M,Anker SD,Butler J,Filippatos G,Pocock SJ,Carson P,Januzzi J,Verma S,Tsutsui H,Brueckmann M,Jamal W,Kimura K,Schnee J,Zeller C,Cotton D,Bocchi E,Böhm M,Choi DJ,Chopra V,Chuquiure E,Giannetti N,Janssens S,Zhang J,Gonzalez Juanatey JR,Kaul S,Brunner-La Rocca HP,Merkely B,Nicholls SJ,Perrone S,Pina I,Ponikowski P,Sattar N,Senni M,Seronde MF,Spinar J,Squire I,Taddei S,Wanner C,Zannad F,EMPEROR-Reduced Trial Investigators., Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. The New England journal of medicine. 2020 Oct 8
[PubMed PMID: 32865377]
[42]
McMurray JJV,Solomon SD,Inzucchi SE,Køber L,Kosiborod MN,Martinez FA,Ponikowski P,Sabatine MS,Anand IS,Bělohlávek J,Böhm M,Chiang CE,Chopra VK,de Boer RA,Desai AS,Diez M,Drozdz J,Dukát A,Ge J,Howlett JG,Katova T,Kitakaze M,Ljungman CEA,Merkely B,Nicolau JC,O'Meara E,Petrie MC,Vinh PN,Schou M,Tereshchenko S,Verma S,Held C,DeMets DL,Docherty KF,Jhund PS,Bengtsson O,Sjöstrand M,Langkilde AM,DAPA-HF Trial Committees and Investigators., Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. The New England journal of medicine. 2019 Nov 21
[PubMed PMID: 31535829]
[43]
Heerspink HJL,Stefánsson BV,Correa-Rotter R,Chertow GM,Greene T,Hou FF,Mann JFE,McMurray JJV,Lindberg M,Rossing P,Sjöström CD,Toto RD,Langkilde AM,Wheeler DC,DAPA-CKD Trial Committees and Investigators., Dapagliflozin in Patients with Chronic Kidney Disease. The New England journal of medicine. 2020 Oct 8
[PubMed PMID: 32970396]